Nutrition and Medical Diet in Geriatric Cancer Patients

tibbi onkoloji ozel 13-4 kapak

Özden ÖZERa, Tuğba YAVUZŞENb

aDokuz Eylül Üniversitesi Onkoloji Enstitüsü, Tıbbi Onkoloji BD, İzmir, TÜRKİYE
bDokuz Eylül Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji BD, İzmir, TÜRKİYE

ABSTRACT
Elderly cancer patients are high-risk patients in terms of malnutrition. Malnutrition is associated with high morbidity/mortality, decreased quality of life, an increase in oncological toxicity and a decrease in efficacy. Body mass index (BMI), weight loss and serum albumin are commonly used parameters in the screening of malnutrition. It is very important to give nutritional support to patients who are at risk with the screening of malnutrition in the early period.
Keywords: Malnutrition; elderly; cachexia; nutrition; medical diet

Referanslar

  1. Siegel Rl Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7-34. [Crossref]  [PubMed]
  2. Pressoir m, Desne s, Berchery D, Rossignol G, Poiree B, meslier m, et al. Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres. Br J Cancer. 2010;102(6):966e71. [Crossref]  [PubMed]  [PMC]
  3. Findlay m, Bauer J, Brown T, et al: Evidence based practice guidelines for nutritional management of patients with head and neck cancer, COsA, 2011.
  4. Wie GA, Cho YA, Kim sY, Kim sm, Bae Jm, Joung h. Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea. Nutrition. 2010;26(3):263e8. [Crossref]  [PubMed]
  5. Sobotka l, editor. Basics in clinical nutrition. 4th ed. Galen; 2012.
  6. Cruz-Jentoft AJ, Kiesswetter E, Drey m, et al. Nutrition, frailty, and sarcopenia.Aging Clin Exp Res. 2017; 29:43-8. [Crossref]  [PubMed]
  7. Bozetti F. Why the oncologist should consider the nutritional status of the elderly cancer patient. Nutrition. 2015;31:590-3 [Crossref]  [PubMed]
  8. Evans WJ, morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr. 2008;27:793-9. [Crossref]  [PubMed]
  9. Muscaritoli m, Anker sD, Argiles J, Aversa Z, Bauer Jm, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special Interest Groups (sIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". Clin Nutr. 2010;29:154-9. [Crossref]  [PubMed]
  10. Cruz-Jentoft AJ, Baeyens JP, Bauer Jm, Boirie Y, Cederholm T, landi F, et al. sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in Older People. Age Ageing. 2010;39: 412-23. [Crossref]  [PubMed]  [PMC]
  11. Jain R, Dotan E: Nutrition and Aging: a Practicing Oncologist's Perspective Curr Oncol Rep. 19:71, 2017 [Crossref]  [PubMed]
  12. Ferguson m, Capra s, Bauer J, et al: Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition.1999;15:458-64. [Crossref]  [PubMed]
  13. Rubenstein lZ, harker JO, salva A, et al: screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (mNA-sF). J Gerontol A Biol sci med sci. 2001;56:m366-72, [Crossref]  [PubMed]
  14. Elia m: The 'mUsT' report. Nutritional screening for adults: a multidisciplinary responsibility. Development and use of the 'malnutrition Universal screening Tool' ('mUsT') for adults., A report by the malnutrition Advisory Group of the British Association for Parenteral and Enteral Nutrition. IsBN 1 899467 70X,2003
  15. Kondrup J, Rasmussen hh, hamberg O, et al: Nutritional risk 300 screening (NRs 2002): a new method based on an analysis of controlled clinical trials. Clinical nutrition.2003; 22:321-36. [Crossref]  [PubMed]
  16. Marion secher mEs, hélène Villars, Gabor Abellan van Kan and Bruno Vellas The mini Nutritional Assessment (mNA) after 20 years of research and clinical practice. . Clinical Gerontology. 2007;17:293310. [Crossref]
  17. Russell CA, Elia m: Nutrition screening survey in the UK and Republic of Ireland in 2010, A report by BAPEN, BAPEN, 2011.
  18. Guigoz Y, Vellas B, Garry PJ: Assessing the nutritional status of the elderly: The mini Nutritional Assessment as part of the geriatric evaluation. Nutr Rev. 1996;54:s59-65, [Crossref]  [PubMed]
  19. Isenring E, Cross G, Daniels l, et al: Validity of the malnutrition screening tool as an effective predictor of nutritional risk in oncology outpatients receiving chemotherapy. support Care Cancer.2006;14:1152-6. [Crossref]  [PubMed]
  20. Arrieta O, michel Ortega Rm, VillanuevaRodr_ıguez G, serna-Thom_e mG, Flores-Estrada D, Diaz-Romero C, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with
  21. Bachmann J, heiligensetzer m, KrakowskiRoosen h, Büchler mW, Friess h, martignoni mE. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest surg. 2008;12:1193-201. [Crossref]  [PubMed]
  22. Bosaeus I, Daneryd P, lundholm K. Dietary intake, resting energy expenditure,weight loss and survival in cancer patients. J Nutr. 2002;132:3465-6. [Crossref]  [PubMed]
  23. Davis mP, Yavuzsen T, Kohshknabi D, Kirkova J, Walsh D, lasheen W, et al. Bioelectrical impedance phase angle changes during hydration and prognosis in advanced cancer. Am J hosp Palliat Care. 2009;26:180-7. [Crossref]  [PubMed]
  24. Gupta D, lis CG, Dahlk sl, Vashi PG, Grutsch JF, lammersfeld CA. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr 2004;92:957-62. [Crossref]  [PubMed]
  25. Crumley ABC, mcmillan m, mcKennan m, mcDonald AC, stuart RC. Evaluation of an inflammation-based prognostic score in patients with inoperab31le gastrooesophageal cancer. Br J Cancer. 2006;94:437-41. [Crossref]  [PubMed]  [PMC]
  26. Arends J, Bachmann P, Baracos V, et al. EsPEN guidelines on nutrition in cancer patients. Clin Nutr.2017;36:11-48. [Crossref]  [PubMed]
  27. Hubbard GP, Elia m, holdoway A, stratton RJA. systematic review of compliance to oral nutritional supplements. Clin Nutr. 2012;31(3):293-312. [Crossref]  [PubMed]
  28. Knox ls. Energy expenditure in malnourished cancer patients. Ann surg 1983;197(2):152- 62. [Crossref]  [PubMed]  [PMC]
  29. Bozetti F. Nutritional support and tumour growth in humans: a narrative review of the literature. Clin Nutr. 2009 226-30 [Crossref]  [PubMed]
  30. Bozetti F. Nutritional support of the oncology patient. Critical Reviews in Oncology/hematology. 2013;87:172-200 [Crossref]  [PubMed]
  31. Volpi E, Kobayashi h, sheffield-moore m, mittendorfer B, Wolfe RR. Essential amino acids are primarily responsible for the amino acid stimulation of muscle protein anabolism in healthy elderly adults. Am J Clin Nutr [Internet]. 2003;78(2):250-8. [Crossref]  [PubMed]  [PMC]
  32. Houston DK, Protein Intake and mobility limitation in Community-Dwelling Older Adults: the health ABC study. J Am Geriatr soc. 2017; 65:1705-11 [Crossref]  [PubMed]  [PMC]
  33. Hélio José Coelho-Júnior Nutrients 2018, 10, 1334 [Crossref]  [PubMed]  [PMC]
  34. Ananieva E. Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World J Biol Chem [Internet]. 2015;6(4):281-9. [Crossref]  [PubMed]  [PMC]
  35. Azrad m, Turgeon C, Demark-Wahnefried W. Current evidence linking polyunsaturated fatty acids with cancer risk and progression. Front Oncol. 2013;3:224. [Crossref]  [PubMed]  [PMC]
  36. Pappalardo G, Almeida A, Ravasco P. Eicosapentaenoic acid in cancer improves body composition and modulates metabolism. Nutrition. 2015;31(4):549-55. [Crossref]  [PubMed]
  37. Laviano A, Rianda s, molfino A, Rossi Fanelli F. Omega-3 fatty acids in cancer. Curr Opin Clin Nutr metab Care. 2013;16:156-61. [Crossref]  [PubMed]
  38. Colomer R, moreno-Nogueira Jm, Garcíaluna PP, et al. n-3 Fatty acids, cancer and cachexia: a systematic review of the literature. Br J Nutr. 2007;97: 823-31 [Crossref]  [PubMed]
  39. Mochamat, henning Cuhls, mika marinova Journal of Cachexia, sarcopenia and muscle. 2017; 8:25-39. [Crossref]  [PubMed]  [PMC]
  40. Rock Cl. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012;62:243-74 [Crossref]  [PubMed]
  41. Miller s, mcNutt l, mcCann m-A, mcCorry N. Use of corticosteroids for anorexia in palliative medicine: a systematic review. J Palliat med. 2014;17(4):482-5. [Crossref]  [PubMed]
  42. Ruiz Garcia V, lópez-Briz E, Carbonell sanchis R, Gonzalvez Perales Jl, Bort-marti s. megestrol acetate for treatment of anorexiacachexia syndrome. In: Ruiz Garcia V, editor. Cochrane database of systematic reviews. Chichester: John Wiley & sons, ltd; 2013. p. CD004310. [Crossref]  [PubMed]  [PMC]
  43. Vijayvergia N, Denlinger Cs. lifestyle factors in cancer survivorship: where we are and where we are headed. J Pers med [Internet]. 2015;5(3):243-63. [Crossref]  [PubMed]  [PMC]
  44. Presley CJ, Dotan E, soto-Perez-deCelis E, Jatoi A, mohile sG, Won E, et al. Gaps in nutritional research among older adults with cancer. J Geriatr Oncol. 2016;7(4):281. [Crossref]  [PubMed]  [PMC]